Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses.
about
The influence of innate and adaptive immune responses on atherosclerosisInflammation and its resolution as determinants of acute coronary syndromes.Co-stimulation of PAFR and CD36 is required for oxLDL-induced human macrophages activation.Uptake of oxLDL and IL-10 production by macrophages requires PAFR and CD36 recruitment into the same lipid rafts.NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species.Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.How an artery heals.Lipoprotein (a) in calcific aortic valve disease: from genomics to novel drug target for aortic stenosis.Molecular biology of atherosclerosis.ApoB versus non-HDL-cholesterol: diagnosis and cardiovascular risk management.Obesity modulates the immune response to oxidized LDL in hypertensive patients.Oxidized LDL induces alternative macrophage phenotype through activation of CD36 and PAFR.The immunology of atherosclerosis.Regulation of pro- and anti-atherogenic cytokines.Innate immune receptor NOD2 promotes vascular inflammation and formation of lipid-rich necrotic cores in hypercholesterolemic mice.
P2860
Q27000370-A0FBC184-579A-41C5-96C4-034B10473421Q33834800-8FF505F0-BE98-4FB4-8102-F23C72E6F8B2Q34263376-A24CF8EE-5C56-4B40-B593-66EB5E16B805Q35018608-A7537FF6-4423-49D9-BFE3-06A02C779847Q35451519-A0BD2A03-900E-4105-B44E-526A4151E269Q36279562-E93BC90E-F332-4F70-BB52-6CC2661BABE0Q36329387-49B0C5B3-6E2C-4D34-B797-E325D55C0069Q36930213-3E22B02E-C46B-4FB3-BDDA-F90C0A41CC8CQ38125279-B54FEE6D-2607-44C8-977A-6119313514B2Q38167825-7A2DEC63-5A92-4B3D-8815-06090D959BBDQ38316537-5704937F-7527-44C9-9BCE-E11AA5296884Q39092512-142A1AC1-07AB-44F7-89DE-1DF34161073AQ39230390-F751CD66-43BD-4B0A-A97B-7DD7529B7924Q47314271-D083A635-14EE-4DFA-BCDD-AA8FE08D3918Q54198287-BC19429E-8240-4E94-AD63-EBA99C1011B4
P2860
Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of a danger-ass ...... nate proatherogenic responses.
@ast
Identification of a danger-ass ...... nate proatherogenic responses.
@en
Identification of a danger-associated peptide from apolipoprotein B100
@nl
type
label
Identification of a danger-ass ...... nate proatherogenic responses.
@ast
Identification of a danger-ass ...... nate proatherogenic responses.
@en
Identification of a danger-associated peptide from apolipoprotein B100
@nl
prefLabel
Identification of a danger-ass ...... nate proatherogenic responses.
@ast
Identification of a danger-ass ...... nate proatherogenic responses.
@en
Identification of a danger-associated peptide from apolipoprotein B100
@nl
P2093
P50
P1433
P1476
Identification of a danger-ass ...... nnate proatherogenic responses
@en
P2093
Gunilla N Fredrikson
Göran K Hansson
Huiqing Liu
Jan Nilsson
Magnus Gidlund
Yajuan Wang
Zhong-Qun Yan
P304
2433-43, 1-7
P356
10.1161/CIRCULATIONAHA.111.051599
P407
P577
2011-11-07T00:00:00Z